BamSEC and AlphaSense Join Forces
Learn More

Context Therapeutics Inc. – Material Contracts

NASDAQ: CNTX    
Share price (7/8/26): $0.60    
Market cap (7/8/26): $54.7 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 6 pages First Amendment to License Agreement
12/34/56
EX-10.2
from 10-Q 31 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential Licence Agreement Between Lonza Sales AG and Context Therapeutics Inc. 1
12/34/56
EX-10.1
from 10-Q 9 pages Confidential
12/34/56
EX-10.1
from 8-K 5 pages Amendment No. 1 to Sales Agreement
12/34/56
EX-10.3
from 10-Q 26 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 7 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Material contract
12/34/56
EX-10.19
from 10-K 36 pages Master Services Agreement
12/34/56
EX-10.15
from 10-K 5 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1
from 8-K 47 pages Context Therapeutics Inc. Shares of Common Stock ($0.001 Par Value Per Share) Sales Agreement
12/34/56
EX-10.1
from 8-K 56 pages License Agreement
12/34/56
EX-10.6
from 10-Q 2 pages Context Therapeutics Inc. 2021 Long -Term Performance Incentive Plan Stock Option Agreement Options Exercisable on or After [•] Non-Qualified Stock Options [•]
12/34/56
EX-10.5
from 10-Q 3 pages Context Therapeutics Inc. Stock Option Agreement
12/34/56
EX-10.4
from 10-Q 27 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 21 pages Asset Purchase Agreement
12/34/56
EX-10.2
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 8 pages Amendment 2 to Research Collaboration and License Agreement
12/34/56
EX-10.24
from 10-K 2 pages Termination Agreement of the Clinical Trial Collaboration and Supply Agreement
12/34/56
EX-10.23
from 10-K 3 pages Amendment 1 to Research Collaboration and License Agreement
12/34/56